121.
The role of vaccination in risk mitigation and control of Newcastle disease in poultry
by Mayers, Jo
Vaccine, 2017-10-20, Vol.35 (44), p.5974-5980
122.
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at...
by Wood, DA, Prof
The Lancet (British edition), 2008, Vol.371 (9629), p.1999-2012
123.
Potential role of the intestinal microbiota in programming health and disease
by Goulet, Olivier
Nutrition reviews, 2015-08, Vol.73 (suppl_1), p.32-40
124.
Modelling vaccination strategies against foot-and-mouth disease
by Keeling, M. J
Nature (London), 2003-01-09, Vol.421 (6919), p.136-142
125.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlle...
by Colhoun, Helen M
The Lancet (British edition), 2004, Vol.364 (9435), p.685-696
126.
In ovo evaluation of FloraMax®-B11 on Marek's disease HVT vaccine protective efficacy, hatchability, microbiota composition, morphometric analysis, and Salmonella enteritidis infec...
by Teague, K D
Poultry science, 2017-07-01, Vol.96 (7), p.2074-2082
127.
Associations between food and beverage groups and major diet‐related chronic diseases: an exhaustive review of pooled/meta‐analyses and systematic reviews
by Fardet, Anthony
Nutrition reviews, 2014-12, Vol.72 (12), p.741-762
128.
Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype...
by Tian, Kai-yue
Vaccine, 2020-02-18, Vol.38 (8), p.1989-1997
129.
Potential risk associated with animal culling and disposal during the foot-and-mouth disease epidemic in Japan in 2010
by Hayama, Yoko
Research in veterinary science, 2015-10, Vol.102, p.228-230
130.
Principles of Neuroplasticity-Based Rehabilitation
by Nahum, Mor
Progress in Brain Research, 2013, Vol.207, p.141-171
131.
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obe...
by Williams, Roger, Prof
The Lancet (British edition), 2014, Vol.384 (9958), p.1953-1997
132.
Selenium and coenzyme Q10 interrelationship in cardiovascular diseases – A clinician's point of view
by Alehagen, Urban
Journal of trace elements in medicine and biology, 2015-07, Vol.31, p.157-162
133.
Scaling up interventions for chronic disease prevention: the evidence
by Gaziano, Thomas A, Dr
The Lancet (British edition), 2007, Vol.370 (9603), p.1939-1946
134.
Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes
by Federizon, Jasmin
Vaccine, 2020-01-22, Vol.38 (4), p.942-950
135.
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial
by Molina, Jean-Michel
The Lancet infectious diseases, 2018-03, Vol.18 (3), p.308-317
136.
The World Heart Federation's vision for worldwide cardiovascular disease prevention
by Yusuf, Salim, Dr
The Lancet (British edition), 2015, Vol.386 (9991), p.399-402
137.
Mediterranean food pattern and the primary prevention of chronic disease: recent developments
by Martinez-Gonzalez, Miguel Angel
Nutrition reviews, 2009-05, Vol.67 (s1), p.S111-S116
138.
Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens
by Ferreira, Helena L
Vaccine, 2020-07-22, Vol.38 (34), p.5507-5515
139.
Spironolactone Decreases DOCA–Salt–Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes
by Amador, Cristián A
Hypertension (Dallas, Tex. 1979), 2014-04, Vol.63 (4), p.797-803
140.
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial
by Schwameis, Michael, MD
The Lancet infectious diseases, 2016, Vol.17 (3), p.322-329
